Search Results

You are looking at 1 - 10 of 33 items for :

  • Continuous glucose monitoring x
  • All content x
Clear All
Open access

Betty Korljan Jelaska, Sanja Baršić Ostojić, Nina Berović, and Višnja Kokić

either direction. It has been shown previously that glucose levels obtained by continuous subcutaneous glucose monitoring (CGM) correspond to those obtained by venous blood sampling or self-measurements (4) (5) . To evaluate the actual prevalence of

Open access

Marcela Rodríguez Flores, Ruth Carmina Cruz Soto, Verónica Vázquez Velázquez, Reina Ruth Soriano Cortés, Carlos Aguilar Salinas, and Eduardo García García

diabetes of 66 ± 24, respectively ( 3 ), compared with values reported for Hispanic population of 21.6 ± 12.6 obtained from a multi-ethnic study ( 6 ). Continuous glucose monitoring has also been helpful to confirm the presence of hypoglycemia in patients

Open access

Harmony Thompson, Helen Lunt, Cate Fleckney, and Steven Soule

to offer some benefits over and above conventional continuous glucose monitoring within the context of this patient’s inpatient admission: It is factory calibrated so does not require calibration using capillary tests ( 6 ). The sensor is placed in

Open access

Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, and Margareth Afonso Torres

performed in the same clinical laboratory (Carlos Chagas, Cuiabá, Brazil). Figure 2 Evaluation with a continuous glucose monitoring system (CGMS) during 72 h. Top graph: patient #1, obtained in May 2014. Bottom graph: patient #2, obtained in

Open access

E S Scott, G R Fulcher, and R J Clifton-Bligh

continuous glucose monitoring (CGM) may be an effective tool to manage these individuals. In particular, recent advances with predictive low-glucose management (PLGM) suspend, as in the Medtronic MiniMed 640G, may facilitate hypoglycaemia avoidance. Here, we

Open access

Peter Novodvorsky, Emma Walkinshaw, Waliur Rahman, Valerie Gordon, Karen Towse, Sarah Mitchell, Dinesh Selvarajah, Priya Madhuvrata, and Alia Munir

test (OGTT) is considered to be risky in patients after bariatric surgery due to its potential to cause DS as a result of altered glycaemic responses. Alternative approaches such as capillary glucose monitoring or the use of continuous glucose

Open access

Sally K Abell, Jessie Teng, Anthony Dowling, Michael S Hofman, Richard J MacIsaac, and Nirupa Sachithanandan

be helpful in some patients (7) . Hence, blood glucose levels should always be monitored closely when initiating therapy with octreotide or following dose escalation in all patients with malignant insulinoma. In our patient, protracted and life

Open access

S A A van den Berg and C G Krol

% glucose), glucose concentration increased to 2.9 mmol/L, after which she regained full consciousness. Upon admission to the hospital, glucose concentration was again low (1.6 mmol/L) and a continuous glucose infusion (5%, 2 L/24 h) was started

Open access

D Cappellani, C Sardella, M C Campopiano, A Falorni, P Marchetti, and E Macchia

demonstrated varying efficacy in the management of IAS ( 4 , 11 ). Independently from the kind of therapeutic approach adopted, frequent glucose monitoring during the follow-up seems advisable. Because the application of continuous glucose monitoring to this

Open access

Aoife Garrahy, Matilde Bettina Mijares Zamuner, and Maria M Byrne

. HbA1C units: mmol/mol. Treatment A blinded iPro 2 continuous glucose monitor (Medtronic Inc.) was applied and the patient was asked to record her capillary blood glucose readings and document any symptoms of hypoglycaemia. On day two